0 results for 'OMelveny Myers'
O'Melveny Continues Its Capital Climb
O'Melveny & Myers may be a West Coast firm, but it's doing pretty well in Washington. Chairman Arthur Culvahouse and other high-profile hires are based in D.C., and the firm's center of power seems to be shifting this way.
Latham, O'Melveny Help Ink Chinese Buy of U.S. Company
Chinese genome research and sequencing company BGI-Shenzhen has finalized its $117 million purchase of genome sequencing company Complete Genomics, marking the first acquisition of a U.S. public company by a Chinese acquirer. O'Melveny & Myers advised BGI; Latham & Watkins advised Complete Genomics.
Litigator of the Week: Daniel Petrocelli of O'Melveny & Myers
Publication Date: 2013-01-17 Practice Area: Industry: Court: Judge: Attorneys: For plaintiff: For defendant: Case number:
Among fans of the cartoonists who created Superman and famously sold off their rights to the character for peanuts in the 1930s, O'Melveny's Petrocelli is sometimes painted as a villain. But he's definitely a superhero to his client, Warner Brothers Entertainment, which is now tantalizingly close to fighting off nine-year-old copyright claims brought by the creators' heirs.
O'Melveny Says Plaintiffs Confuse Advocacy With Misrepresentation
O'Melveny & Myers, fighting to dismiss a state suit brought by alumni of an elite Brooklyn prep school that was represented by the firm in a prior federal action, said the alumni cannot sue the firm with "previously abandoned" claims of purported deception on the courts.
O'Melveny Beats Back Hitachi Patent Claims in East Texas Trial Against TPV
Publication Date: 2013-04-15 Practice Area: Industry: Court: Judge: Attorneys: For plaintiff: For defendant: Case number:
Lawyers at O'Melveny & Myers convinced an East Texas jury to side with television manufacturer TPV Technology Ltd. in a patent case brought by Hitachi Ltd.
O'Melveny Wins Injunction for Allergan in Botox Trade Secrets Case
Publication Date: 2012-03-07 Practice Area: Industry: Court: Judge: Attorneys: For plaintiff: For defendant: Case number:
Allergan execs probably grew some new frown lines when sales representatives for Botox, the company's best-selling wrinkle treatment, jumped ship for rival Merz Pharma GmbH just as Merz was rolling out a rival drug. Now its Merz that should be worried, though, thanks to a bench ruling that Allergan's lawyers at O'Melveny & Myers won on Tuesday.
Trending Stories
- 1Joshua Wright's $108M Defamation Case Against Former Students to Proceed to Trial
- 2AI: Looking at Its Impact on the Legal Profession in 2025 and Beyond
- 3AI/IP Issues Part 2: What Current Litigation Can Tell Us About Where IP in AI Is Heading
- 4AI/IP Issues Part 1: State of the Law and Anticipating Issues Including Licensing Concerns
- 5Biden Picks Nominees for US District Judgeships in Pennsylvania, California and Minnesota
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
Resources
Unlocking the Power of Early Case Assessment Workflows
Brought to you by Integreon
Download Now
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now